Knight Therapeutics Inc. KHTRF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.77M | 4.08M | -4.00M | -2.68M | 130.90K |
| Total Depreciation and Amortization | 45.66M | 43.59M | 39.86M | 39.06M | 35.98M |
| Total Amortization of Deferred Charges | 705.10K | 705.10K | 705.10K | 662.90K | 662.90K |
| Total Other Non-Cash Items | 18.88M | 12.76M | 11.46M | 4.22M | 575.50K |
| Change in Net Operating Assets | 7.37M | 15.57M | 1.57M | -15.63M | -15.43M |
| Cash from Operations | 83.39M | 76.70M | 49.59M | 25.62M | 21.92M |
| Capital Expenditure | -3.53M | -3.53M | -1.37M | -1.41M | -1.38M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 20.90K | 92.30K | 92.30K |
| Cash Acquisitions | -8.42M | -79.57M | -79.57M | -79.57M | -77.25M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.69M | 13.23M | 25.78M | 41.93M | 49.06M |
| Cash from Investing | -265.70K | -69.88M | -55.14M | -38.95M | -29.48M |
| Total Debt Issued | 867.00K | 110.26M | 112.07M | 111.75M | 113.38M |
| Total Debt Repaid | -85.78M | -103.27M | -93.44M | -71.56M | -69.59M |
| Issuance of Common Stock | 1.02M | 734.00K | 736.00K | 743.00K | 1.07M |
| Repurchase of Common Stock | -12.28M | -11.24M | -6.35M | -8.50M | -10.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.56M | -7.68M | -7.60M | -7.57M | -7.05M |
| Cash from Financing | -74.20M | -8.06M | 4.20M | 18.19M | 19.60M |
| Foreign Exchange rate Adjustments | 2.68M | -1.49M | -2.08M | 135.80K | -500.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.61M | -2.73M | -3.43M | 5.00M | 11.54M |